#!/usr/bin/env node
/**
 * Script: seed-blog-posts.mjs
 * Seeds the first 5 SEO blog posts for Peptide Alliance.
 * Run from project root: node scripts/seed-blog-posts.mjs
 */

import { createClient } from '@supabase/supabase-js';
import { readFileSync } from 'fs';
import { resolve } from 'path';

// ── Load .env.local ────────────────────────────────────────────────────────────
const envPath = resolve(process.cwd(), '.env.local');
let supabaseUrl, serviceKey;
try {
  const env = readFileSync(envPath, 'utf8');
  for (const line of env.split('\n')) {
    const [key, ...rest] = line.split('=');
    const val = rest.join('=').trim().replace(/^["']|["']$/g, '');
    if (key?.trim() === 'NEXT_PUBLIC_SUPABASE_URL') supabaseUrl = val;
    if (key?.trim() === 'SUPABASE_SERVICE_ROLE_KEY') serviceKey = val;
  }
} catch {
  supabaseUrl = process.env.NEXT_PUBLIC_SUPABASE_URL;
  serviceKey = process.env.SUPABASE_SERVICE_ROLE_KEY;
}

if (!supabaseUrl || !serviceKey) {
  console.error('❌  Missing NEXT_PUBLIC_SUPABASE_URL or SUPABASE_SERVICE_ROLE_KEY');
  process.exit(1);
}

const supabase = createClient(supabaseUrl, serviceKey, {
  auth: { persistSession: false, autoRefreshToken: false },
});

const NOW = new Date().toISOString();

const posts = [

  // ── Post 1 ───────────────────────────────────────────────────────────────────
  {
    slug: 'bpc-157-complete-guide-healing-peptide',
    title_en: 'BPC-157: The Complete Guide to This Powerful Healing Peptide',
    excerpt_en: 'BPC-157 is one of the most researched healing peptides available today. This complete guide covers what BPC-157 is, how it works, its benefits for injury recovery, gut health, and joint repair, plus dosing protocols and how to find a verified supplier.',
    category: 'peptide_education',
    meta_title_en: 'BPC-157 Complete Guide: Benefits, Dosage & How It Works | Peptide Alliance',
    meta_description_en: 'Everything you need to know about BPC-157 — the body protection compound that supports injury healing, gut repair, and joint recovery. Learn about dosing, sourcing, and verified suppliers.',
    content_en: `BPC-157 — short for **Body Protection Compound-157** — is a synthetic peptide derived from a protein found in human gastric juice. It has become one of the most widely discussed peptides in the research and wellness communities, largely because of its remarkable regenerative properties across a wide range of tissues.

This guide covers everything you need to know about BPC-157: what it is, how it works, what the research says, typical dosing protocols, and how to find a reputable source.

## What Is BPC-157?

BPC-157 is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that was first isolated from human gastric juice. It is considered a **stable gastric pentadecapeptide**, meaning it maintains stability in both gastric acid and blood plasma — an important factor that distinguishes it from many other peptides.

Unlike growth hormone secretagogues or anabolic peptides, BPC-157 does not work through the hypothalamic-pituitary axis. Instead, it operates primarily through **local tissue repair mechanisms**, upregulating growth factors, stimulating angiogenesis (new blood vessel formation), and modulating nitric oxide pathways.

## How Does BPC-157 Work?

BPC-157 exerts its effects through several overlapping mechanisms:

- **Upregulation of growth hormone receptors** in healing tissue, accelerating the response to endogenous GH
- **Stimulation of VEGF** (vascular endothelial growth factor), promoting new blood vessel formation in damaged areas
- **Modulation of the nitric oxide system**, which plays a critical role in blood flow and tissue repair
- **Tendon and ligament healing** via direct stimulation of tendon fibroblast migration and proliferation
- **Gut barrier protection** by preserving the integrity of gastrointestinal epithelium and countering NSAID-induced damage

Research in animal models consistently shows that BPC-157 accelerates healing of tendons, ligaments, muscle, bone, gut tissue, and even peripheral nerves — often significantly faster than control groups.

## Key Benefits of BPC-157

### Injury and Musculoskeletal Recovery

BPC-157 has perhaps the strongest evidence base in the area of **tendon, ligament, and muscle repair**. Studies in rodent models have demonstrated:

- Accelerated healing of Achilles tendon transections
- Faster recovery from rotator cuff injuries
- Improved healing outcomes for bone fractures
- Reduced inflammation in crush injuries and muscle tears

Athletes and active individuals frequently report using BPC-157 to address persistent tendon injuries — particularly Achilles tendinopathy, patellar tendinopathy, and lateral epicondylitis — that have been resistant to conventional treatment.

### Gastrointestinal Health

BPC-157 was originally studied for its gastroprotective effects. Research shows it can:

- Heal gastric ulcers and intestinal fistulas
- Counteract NSAID-induced gut damage
- Reduce intestinal permeability ("leaky gut")
- Protect against inflammatory bowel conditions in animal models

This makes BPC-157 particularly interesting for individuals with chronic gut issues, especially those who take anti-inflammatory medications regularly.

### Joint and Cartilage Repair

Studies suggest BPC-157 can help with **cartilage degradation** and joint inflammation. Its ability to promote angiogenesis in avascular tissue (like cartilage) is especially notable, as poor blood supply is one of the primary reasons cartilage repairs so slowly under normal conditions.

### Neurological Benefits

Early research indicates BPC-157 may have neuroprotective and neuroregenerative properties, including:

- Protecting dopamine neurons from neurotoxic damage
- Improving recovery after traumatic brain injury in animal models
- Reducing symptoms of depression and anxiety in rodent studies through serotonin and dopamine modulation

---

## BPC-157 Dosing Protocols

**Standard research dosing** in animal studies typically uses doses ranging from 1–10 mcg/kg body weight. Extrapolated to human equivalents, most protocols in the nootropic and peptide community use:

- **Subcutaneous (SC) or intramuscular (IM) injection:** 200–500 mcg per day
- **Oral/capsule form:** 500–1000 mcg per day (lower bioavailability but useful for gut-targeted effects)

Common protocols run **4–8 week cycles**, with a similar break period. Injections are typically administered once or twice daily, with many users injecting as close to the site of injury as practical.

### BPC-157 Injection vs. Oral Administration

The choice between injectable and oral BPC-157 depends on the target:

- **Systemic injuries (tendons, joints, muscles):** Injectable form preferred for higher bioavailability
- **Gut and gastrointestinal issues:** Oral/capsule form may be equally or more effective given the direct local action

---

## BPC-157 Safety Profile

BPC-157 has a notably clean safety profile in animal research. Studies have not demonstrated significant toxicity, organ damage, or carcinogenicity at doses well above those used in human protocols. No serious adverse effects have been observed in rodent models even with long-term administration.

That said, **BPC-157 has not undergone formal human clinical trials**. It is currently classified as a research compound and is not approved by the FDA for human use. Anyone considering BPC-157 should do thorough research and ideally consult a qualified healthcare provider familiar with peptide therapies.

Common user-reported side effects are mild and infrequent:

- Temporary nausea (especially with oral administration)
- Mild injection site reactions
- Dizziness (rare)

---

## Finding a Legitimate BPC-157 Source

Quality varies enormously across BPC-157 suppliers. Poor manufacturing practices can result in products that are underdosed, contaminated, or misidentified. When evaluating a BPC-157 supplier, look for:

- **Third-party certificate of analysis (CoA)** from an independent testing lab
- **HPLC purity testing** confirming peptide sequence and identity
- **Endotoxin testing** (critical for injectable peptides)
- **Transparent manufacturing information**

The [Peptide Alliance directory](/peptides/bpc-157) lists verified suppliers with documented quality testing — a useful starting point for sourcing research-grade BPC-157.

---

## Summary

BPC-157 is one of the most compelling healing peptides in preclinical research, with a broad range of potential applications in musculoskeletal repair, gastrointestinal health, and neurological protection. Its unique mechanism — operating independently of the HPA axis — makes it a versatile option in peptide protocols.

While human clinical data remains limited, the animal research is consistently impressive and the safety profile is favorable. For those researching peptide therapies, BPC-157 is widely considered a foundational compound worth understanding in depth.

**Explore verified BPC-157 suppliers** on the [Peptide Alliance database](/peptides) and compare sources by trust score, certifications, and lab results.`,
    is_published: true,
    published_at: NOW,
    generated_by: 'admin',
  },

  // ── Post 2 ───────────────────────────────────────────────────────────────────
  {
    slug: 'how-to-find-legitimate-peptide-supplier-2025',
    title_en: 'How to Find a Legitimate Peptide Supplier in 2025',
    excerpt_en: 'The peptide market is flooded with vendors of wildly varying quality. This guide breaks down exactly what to look for — from CoAs and HPLC testing to red flags that signal a supplier you should avoid.',
    category: 'source_reviews',
    meta_title_en: 'How to Find a Legitimate Peptide Supplier in 2025 | Peptide Alliance',
    meta_description_en: 'Not all peptide suppliers are equal. Learn what separates verified, trustworthy peptide vendors from risky ones — CoAs, HPLC purity, endotoxin testing, and more.',
    content_en: `Finding a high-quality, legitimate peptide supplier is one of the most important decisions a researcher or clinician can make. The peptide market has grown dramatically over the past decade — and with that growth has come a significant increase in vendors offering products of highly variable quality.

This guide walks you through exactly what to look for, what questions to ask, and which red flags to watch out for when evaluating a peptide supplier in 2025.

## Why Peptide Quality Matters

Peptides used for research purposes must meet strict purity and sterility standards — especially if they will be used in injectable applications. Poor-quality peptides can contain:

- **Underdosed active compound** (less peptide than advertised)
- **Incorrect peptide sequences** (entirely wrong product)
- **Bacterial endotoxins** (dangerous for injection; can cause fever, sepsis)
- **Heavy metal contamination**
- **Microbial contamination** (bacteria, fungi)
- **Residual solvents** from synthesis

These aren't hypothetical risks. Testing of peptides purchased from unverified vendors has frequently revealed products that fail purity standards, contain incorrect sequences, or are contaminated with endotoxins. Sourcing from a reputable supplier is non-negotiable.

## What to Look For in a Legitimate Peptide Supplier

### 1. Certificate of Analysis (CoA) from an Independent Lab

Every legitimate peptide supplier should provide a **Certificate of Analysis (CoA)** for every batch of every product. A CoA is a document from a testing laboratory that confirms the peptide's identity, purity, and safety.

Key things to verify on a CoA:

- The testing lab is **independent** (not affiliated with the supplier)
- The CoA is **batch-specific** (not a generic document)
- The document shows **HPLC purity results** (typically presented as a percentage and a chromatogram)
- The CoA includes **mass spectrometry (MS) verification** of the correct molecular weight
- **Endotoxin levels** are listed (critical for injectables)

Be wary of suppliers who provide CoAs without the actual chromatogram images, or whose CoAs come from labs that cannot be independently verified.

### 2. HPLC Purity of 98%+

**High-Performance Liquid Chromatography (HPLC)** is the standard method for measuring peptide purity. It separates the components of a sample and quantifies how much of the total is actually the target peptide.

For research-grade peptides, a minimum purity of **98%** is the accepted standard. Some suppliers advertise 99%+ purity for flagship products. Anything below 95% is concerning; below 90% is unacceptable for any serious research application.

### 3. Endotoxin Testing for Injectable Peptides

Bacterial endotoxins — fragments from the cell walls of gram-negative bacteria — are a critical safety concern for any injectable compound. Endotoxins can cause severe immune reactions including fever, inflammation, and in extreme cases, septic shock.

A legitimate supplier will provide **LAL (Limulus Amebocyte Lysate) testing results** for endotoxin levels. The FDA guideline for parenteral drugs is less than 5 EU/kg/hr of body weight. Look for suppliers who explicitly state endotoxin test results on their CoAs.

### 4. Transparent Manufacturing Information

Reputable peptide suppliers are transparent about how and where their peptides are manufactured. Look for:

- **GMP-adjacent or GMP-compliant manufacturing facilities**
- Information about the **synthesis method** (solid-phase peptide synthesis is standard)
- Clear **storage and shipping protocols** (lyophilized peptides require careful handling)
- Evidence of proper **cold chain management** during shipping

### 5. Third-Party Reviews and Track Record

Beyond documentation, a supplier's reputation in the community matters. Look for:

- Independent reviews on forums and research communities (not just testimonials on their own site)
- History of consistent product quality across multiple batches
- Responsiveness to quality issues and willingness to retest disputed batches
- Length of time in operation

---

## Red Flags to Watch For

### No Independent CoA or Outdated Testing

If a supplier cannot provide a current, batch-specific CoA from an independent laboratory, that is an immediate disqualifier. Recycled CoAs from old batches, or CoAs from internal testing only, do not provide meaningful quality assurance.

### Unusually Low Prices

High-quality peptide synthesis is expensive. Solid-phase synthesis, purification, lyophilization, and third-party testing all add cost. If a supplier's prices are dramatically lower than the market average, it almost always means corners are being cut — on raw materials, synthesis quality, purification, or testing.

This doesn't mean the most expensive supplier is the best — but extreme discounts are a warning sign.

### Vague or Missing Product Information

Legitimate suppliers provide clear information about:

- Peptide sequence and molecular formula
- Molecular weight
- Recommended storage conditions
- Batch number and manufacturing date

Suppliers who can't or won't provide this information are not operating at a professional level.

### No Verifiable Business Presence

Legitimate peptide businesses have a real business presence: a physical address, verifiable contact information, and ideally regulatory registrations appropriate to their jurisdiction. Anonymous or offshore-only suppliers with no traceable business entity represent a higher risk profile.

---

## Types of Peptide Suppliers

### Research Chemical Companies

The most common source of peptides for research purposes. These companies sell peptides explicitly labeled "for research use only" and are not intended for human use. Quality varies dramatically — which is precisely why due diligence on CoAs and testing is so important.

### Compounding Pharmacies

In the United States, **FDA-registered compounding pharmacies** can produce peptide preparations for specific patients under a prescription from a licensed physician. Compounding pharmacies operate under a different regulatory framework than research chemical companies and generally must meet higher standards for sterility and quality.

For individuals seeking peptide therapy through a clinical pathway, a compounding pharmacy is the appropriate legal channel.

### Peptide Brands (Direct-to-Consumer)

Some peptide brands sell directly to consumers, often positioning their products for specific wellness applications. These companies vary widely in their quality standards and transparency.

---

## Using the Peptide Alliance Directory

The [Peptide Alliance directory](/peptides) is designed specifically to help researchers and clinicians navigate the peptide supplier landscape. Each listed business has a **Trust Score** calculated from:

- Verified certifications and lab results
- Profile completeness
- Customer reviews and ratings
- Subscription tier and claimed ownership

This makes it easy to identify which suppliers have invested in quality verification and business transparency. You can [search verified suppliers](/search) filtered by category, location, and trust score to find the right fit for your research needs.

---

## Summary

Finding a legitimate peptide supplier comes down to documentation and transparency. The non-negotiables are:

1. **Batch-specific CoA from an independent lab**
2. **HPLC purity of 98% or higher**
3. **Endotoxin testing for any injectable product**
4. **Verifiable business presence and track record**

The [Peptide Alliance verified supplier directory](/peptides) is a good starting point for identifying vendors who meet these standards.`,
    is_published: true,
    published_at: NOW,
    generated_by: 'admin',
  },

  // ── Post 3 ───────────────────────────────────────────────────────────────────
  {
    slug: 'glp-1-peptides-semaglutide-tirzepatide-weight-loss-guide',
    title_en: 'GLP-1 Peptides: Semaglutide, Tirzepatide & the Science of Peptide Weight Loss',
    excerpt_en: 'GLP-1 receptor agonists like semaglutide and tirzepatide represent the most significant advance in weight loss pharmacology in decades. This guide explains the science, compares the leading options, and covers what to know before pursuing peptide-based weight management.',
    category: 'peptide_education',
    meta_title_en: 'GLP-1 Peptides: Semaglutide & Tirzepatide Weight Loss Guide | Peptide Alliance',
    meta_description_en: 'A comprehensive guide to GLP-1 receptor agonist peptides for weight loss — including semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). Learn the science, compare options, and find verified compounding pharmacies.',
    content_en: `The rise of **GLP-1 receptor agonist peptides** has fundamentally changed the landscape of weight management medicine. Compounds like **semaglutide** (sold under the brand names Ozempic and Wegovy) and **tirzepatide** (Mounjaro and Zepbound) have demonstrated weight loss results previously considered impossible without surgery — and the scientific community is paying close attention.

This guide explains the science behind GLP-1 peptides, compares the leading options, and covers what anyone considering peptide-based weight management should know.

## What Are GLP-1 Peptides?

**GLP-1 (glucagon-like peptide-1)** is a hormone naturally produced in the gut in response to food intake. It plays several important roles in metabolic regulation:

- Stimulates insulin secretion from the pancreas (glucose-dependent)
- Suppresses glucagon release, reducing hepatic glucose production
- Slows gastric emptying, prolonging the feeling of fullness
- Acts on the hypothalamus to reduce appetite and food-seeking behavior

GLP-1 receptor agonists are synthetic peptides designed to mimic and amplify these effects. They bind to GLP-1 receptors throughout the body — including in the pancreas, brain, and gut — with a much longer half-life than naturally occurring GLP-1, allowing for once-weekly dosing.

## Semaglutide: The Current Standard Bearer

**Semaglutide** is a GLP-1 receptor agonist originally developed for type 2 diabetes management (Ozempic) that was later approved at a higher dose specifically for chronic weight management (Wegovy).

### Clinical Results

The STEP trial program established semaglutide's remarkable efficacy for weight loss:

- **STEP 1:** Participants without diabetes lost an average of **14.9% of body weight** over 68 weeks with 2.4 mg weekly semaglutide versus 2.4% with placebo
- **STEP 4:** Participants who stopped semaglutide regained two-thirds of their lost weight within a year, highlighting the need for ongoing treatment
- Approximately **one-third of participants** lost 20% or more of their body weight

Beyond weight loss, semaglutide has demonstrated significant cardiovascular benefits. The SELECT trial showed a **20% reduction in major adverse cardiovascular events** in overweight or obese adults with established cardiovascular disease.

### How Semaglutide Works for Weight Loss

Semaglutide's weight-loss effects are primarily mediated through the central nervous system. It acts on GLP-1 receptors in the hypothalamus and brainstem to:

- Reduce appetite and food cravings
- Decrease the reward value of food (particularly high-calorie, palatable foods)
- Slow gastric emptying, increasing satiety after smaller meals
- Alter eating behavior at a neurological level, not just through willpower

---

## Tirzepatide: The Dual-Action Advantage

**Tirzepatide** (brand names Mounjaro for diabetes, Zepbound for weight loss) represents the next evolution in this drug class. Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a **dual GIP/GLP-1 receptor agonist** — it activates both the GLP-1 receptor and the **GIP (glucose-dependent insulinotropic polypeptide) receptor**.

### Why Dual Action Matters

GIP is another incretin hormone with complementary metabolic effects to GLP-1. In combination:

- Enhanced insulin secretion and sensitivity
- Greater reduction in appetite and caloric intake
- Potentially superior fat mass reduction compared to GLP-1 alone

### Clinical Results

The SURMOUNT trials have shown tirzepatide to be even more effective than semaglutide for weight loss:

- **SURMOUNT-1:** At the highest dose (15 mg), participants lost an average of **20.9% of body weight** over 72 weeks
- Nearly **37% of participants** at the highest dose achieved weight loss of 25% or more
- Results surpassed those of semaglutide in head-to-head analyses

---

## Retatrutide and Next-Generation Peptides

The pipeline doesn't stop at dual agonists. **Retatrutide** is a **triple GLP-1/GIP/glucagon receptor agonist** currently in Phase 3 trials. Early data suggests even greater efficacy than tirzepatide, with mean weight loss of **24.2%** in Phase 2 trials — approaching the outcomes of bariatric surgery.

---

## Compounding Pharmacies and Access

Due to drug shortages and cost barriers (brand-name semaglutide and tirzepatide can cost $900–$1,300/month without insurance), many patients have sought access through **compounding pharmacies**.

During the FDA's official drug shortage period, licensed compounding pharmacies were permitted to produce semaglutide and tirzepatide compounds. The regulatory status of compounded GLP-1 peptides is evolving — current guidance should always be verified with a licensed healthcare provider and compounding pharmacy.

When using a compounding pharmacy for GLP-1 peptides, it is essential to verify:

- **State licensing** and FDA registration where applicable
- **Sterility testing** for all injectable preparations
- **Certificate of analysis** confirming peptide identity and purity
- **Prescribing physician oversight** — GLP-1 receptor agonists require a valid prescription

The [Peptide Alliance directory](/peptides/weight-loss-metabolic) lists verified compounding pharmacies and peptide clinics that specialize in weight management peptide therapy.

---

## Side Effects and Considerations

GLP-1 receptor agonists are generally well tolerated but do carry meaningful side effects that anyone considering treatment should understand:

**Gastrointestinal effects** are the most common, particularly during dose escalation:
- Nausea (most common, especially early in treatment)
- Vomiting
- Diarrhea or constipation
- Gastroparesis (in rare cases at higher doses)

**Other considerations:**
- **Weight regain on discontinuation** — the metabolic effects are not permanent; weight loss requires ongoing treatment or significant lifestyle changes to maintain
- **Muscle mass loss** — a meaningful portion of weight lost can be lean mass; resistance training and adequate protein intake are strongly recommended
- **Pancreatitis risk** — rare but present; caution advised in those with a history of pancreatitis
- **Thyroid C-cell effects** — contraindicated in those with a personal or family history of medullary thyroid carcinoma

---

## Summary

GLP-1 receptor agonist peptides represent a paradigm shift in metabolic medicine. The clinical evidence for semaglutide and tirzepatide is robust and the weight loss outcomes are unprecedented for a pharmacological intervention. As the next generation of compounds (retatrutide and beyond) approaches approval, this class of peptides will only grow in significance.

For anyone researching GLP-1 peptide therapy, starting with a qualified clinician and a verified compounding pharmacy or licensed prescriber is essential. Explore the [Peptide Alliance weight loss & metabolic peptide directory](/peptides/weight-loss-metabolic) for verified clinics and pharmacies.`,
    is_published: true,
    published_at: NOW,
    generated_by: 'admin',
  },

  // ── Post 4 ───────────────────────────────────────────────────────────────────
  {
    slug: 'cjc-1295-ipamorelin-growth-hormone-peptide-stack-guide',
    title_en: 'CJC-1295 + Ipamorelin: The Growth Hormone Peptide Stack Explained',
    excerpt_en: 'CJC-1295 and Ipamorelin is one of the most popular peptide stacks for growth hormone optimization. This guide explains how each peptide works, why they are often combined, what the research shows, and how to approach dosing.',
    category: 'peptide_education',
    meta_title_en: 'CJC-1295 + Ipamorelin Stack Guide: Dosage, Benefits & How It Works | Peptide Alliance',
    meta_description_en: 'Everything you need to know about the CJC-1295 and Ipamorelin peptide stack — how it stimulates growth hormone, the difference between CJC-1295 with and without DAC, dosing protocols, and expected benefits.',
    content_en: `Among growth hormone-stimulating peptides, the **CJC-1295 + Ipamorelin** stack has become one of the most widely used combinations in peptide therapy and research. The pairing is popular because the two peptides work through complementary but distinct mechanisms, producing a more physiological and robust growth hormone release than either compound alone.

This guide explains how each peptide works, why they are stacked together, what the research shows, and how typical dosing protocols are structured.

## Understanding the Growth Hormone Axis

To understand how CJC-1295 and Ipamorelin work, it helps to understand the basic framework of growth hormone regulation.

The body regulates GH release through two primary hormones from the hypothalamus:

- **GHRH (Growth Hormone Releasing Hormone):** Stimulates the pituitary to release GH
- **Somatostatin:** Inhibits GH release, acting as a brake on the system

GH is released in pulses — primarily during deep sleep and in response to fasting and exercise. These pulses decline significantly with age, which is associated with changes in body composition, recovery capacity, and metabolic health.

Both CJC-1295 and Ipamorelin amplify GH release, but through different pathways.

---

## What Is CJC-1295?

**CJC-1295** is a synthetic analogue of **GHRH (Growth Hormone Releasing Hormone)**, the 44-amino-acid peptide that signals the pituitary gland to release growth hormone.

Natural GHRH has a half-life of only a few minutes in the bloodstream. CJC-1295 was engineered to solve this problem — it contains modifications that dramatically extend its half-life.

### CJC-1295 With DAC vs. Without DAC

This is one of the most commonly confused points in peptide discussions:

- **CJC-1295 with DAC (Drug Affinity Complex):** Binds to albumin in the blood, extending its half-life to **6–8 days**. This creates a sustained, steady elevation in baseline GH levels rather than a pulsatile release. Often called "CJC-1295 with DAC."
- **CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF 1-29):** Has a half-life of approximately **30 minutes**, producing a more pulsatile, physiologically natural GH release. This is the form most commonly stacked with Ipamorelin.

For most protocols focused on preserving the natural pulsatile nature of GH release, **CJC-1295 without DAC (Mod GRF 1-29)** is preferred.

---

## What Is Ipamorelin?

**Ipamorelin** is a **growth hormone secretagogue (GHS)** and **GHRP (Growth Hormone Releasing Peptide)** — specifically, it is a selective **ghrelin receptor agonist (GHSR agonist)**.

Rather than mimicking GHRH, Ipamorelin works through a completely different pathway: it binds to ghrelin receptors in the pituitary gland, triggering GH release independently of GHRH signaling.

### Why Ipamorelin Stands Out Among GHRPs

Earlier GHRPs like GHRP-2 and GHRP-6 also stimulate GH release through ghrelin receptors, but they come with side effects including:

- Significant cortisol and prolactin elevation (GHRP-2)
- Strong appetite stimulation and hunger (GHRP-6)

**Ipamorelin is highly selective** — it stimulates GH release without significantly raising cortisol, prolactin, or ACTH at standard doses. This cleaner profile makes it the preferred GHRP for most protocols.

---

## Why Stack CJC-1295 and Ipamorelin Together?

The combination works so well because CJC-1295 and Ipamorelin act on **two separate but synergistic pathways**:

- **CJC-1295** (GHRH analogue): Amplifies the GHRH signal from the hypothalamus, increasing the magnitude of each GH pulse
- **Ipamorelin** (GHRP): Acts on ghrelin receptors to trigger GH release and simultaneously suppresses somatostatin, removing the brake on GH secretion

The result is a significantly larger GH pulse than either peptide produces alone, while still being **pulsatile and physiologically appropriate** — not a continuous flat elevation in GH.

Research has shown that combining a GHRH analogue with a GHRP can produce **synergistic GH release** far beyond additive effects, making the stack one of the more efficient approaches to GH optimization.

---

## Benefits of the CJC-1295 + Ipamorelin Stack

The benefits associated with optimized GH levels through this stack include:

- **Improved body composition:** Increased lean muscle mass and reduced fat mass, particularly visceral fat
- **Enhanced recovery:** Faster recovery from training and injury through GH's role in protein synthesis and tissue repair
- **Improved sleep quality:** GH is primarily secreted during deep sleep; users frequently report deeper, more restorative sleep
- **Skin and connective tissue health:** GH stimulates collagen synthesis, supporting skin elasticity and joint integrity
- **Metabolic improvements:** Enhanced fat oxidation and insulin sensitivity
- **Anti-aging effects:** Partial reversal of age-related GH decline

---

## Dosing Protocols

Standard research protocols for the CJC-1295 + Ipamorelin stack:

### Typical Dosing

- **CJC-1295 without DAC:** 100–300 mcg per injection
- **Ipamorelin:** 100–300 mcg per injection
- Both are injected simultaneously, typically subcutaneously

### Timing

Timing matters because GH release is governed by somatostatin cycles. Common protocols include:

1. **Before bed:** Most popular option — aligns with the natural overnight GH pulse, with the added benefit of improved sleep quality. Fast for 2–3 hours before injecting.
2. **Upon waking (fasted):** Takes advantage of the natural morning GH pulse and the elevated GH response in a fasted state.
3. **Two or three times daily:** More aggressive protocols used in clinical settings, though not typically necessary for general wellness applications.

### Cycle Length

Most protocols run **3–6 months on, with a 1–2 month break**. Some clinical applications use longer continuous protocols. Cycling helps maintain receptor sensitivity.

---

## What to Expect

Timeline of commonly reported effects:

- **Weeks 1–2:** Improved sleep quality, occasional vivid dreams, mild water retention
- **Weeks 3–6:** Improved recovery, reduced soreness, early changes in body composition
- **Months 2–3:** More noticeable changes in muscle tone and fat reduction, improved skin texture
- **Months 4–6:** Maximum body composition changes, sustained energy and recovery improvements

---

## Finding Verified CJC-1295 and Ipamorelin Sources

As with all research peptides, quality verification is critical. HPLC purity, mass spectrometry confirmation, and endotoxin testing should be confirmed via independent CoA before use.

Browse the [Peptide Alliance directory for growth hormone peptides](/peptides/growth-hormone) to compare verified suppliers with documented quality testing.

---

## Summary

The CJC-1295 + Ipamorelin stack is one of the most scientifically sound approaches to GH optimization available. By combining a GHRH analogue with a selective GHRP, the stack amplifies natural GH release through two independent pathways, producing synergistic results with a favorable safety profile.

For anyone researching growth hormone peptide protocols, this stack represents a well-studied, widely-used starting point.`,
    is_published: true,
    published_at: NOW,
    generated_by: 'admin',
  },

  // ── Post 5 ───────────────────────────────────────────────────────────────────
  {
    slug: 'tb-500-vs-bpc-157-which-healing-peptide-is-right-for-you',
    title_en: 'TB-500 vs BPC-157: Which Healing Peptide Is Right for You?',
    excerpt_en: 'TB-500 and BPC-157 are both widely researched healing peptides, but they work through different mechanisms and have different strengths. This comparison breaks down the science behind each, when to use one vs. the other, and whether combining them makes sense.',
    category: 'research_updates',
    meta_title_en: 'TB-500 vs BPC-157: Which Healing Peptide Is Right for You? | Peptide Alliance',
    meta_description_en: 'A detailed comparison of TB-500 and BPC-157 — two of the most researched healing peptides. Learn the differences in mechanism, benefits, dosing, and when stacking makes sense.',
    content_en: `When it comes to peptides for healing and recovery, **TB-500** and **BPC-157** are consistently at the top of the conversation. Both compounds have significant bodies of preclinical research supporting their regenerative properties, and both are widely used in peptide protocols targeting injury recovery, inflammation, and tissue repair.

But they are not interchangeable. Understanding the differences between TB-500 and BPC-157 — including how each works, what it is best suited for, and how they compare in specific use cases — is essential for anyone designing an effective healing protocol.

## What Is TB-500?

**TB-500** is a synthetic version of **Thymosin Beta-4 (Tβ4)**, a naturally occurring protein found in high concentrations in blood platelets, wound fluid, and virtually all human and animal cells. It is one of the most abundant proteins in the body, which gives some indication of how important it is to fundamental cellular processes.

Thymosin Beta-4's primary function is **actin regulation**. Actin is the structural protein that makes up the cytoskeleton of cells and is critical for cell migration, differentiation, and tissue repair. TB-500 sequesters actin monomers, regulating the balance between free actin and filamentous actin — a process that is fundamental to cellular repair and wound healing.

### Key Mechanisms of TB-500

- **Actin regulation:** Promotes cell migration to sites of injury by modulating actin polymerization
- **Angiogenesis:** Stimulates the formation of new blood vessels in damaged tissue
- **Anti-inflammatory effects:** Reduces inflammatory cytokines at injury sites
- **Keratinocyte and endothelial cell migration:** Promotes healing of skin wounds and vascular injury
- **Stem cell activation:** Research suggests TB-500 may upregulate stem cell factors, promoting differentiation of repair cells

### What TB-500 Is Best For

TB-500 tends to show the strongest effects in:

- **Systemic tissue healing** (it works throughout the body, not just at local injection sites)
- **Cardiac tissue repair** (animal studies show impressive cardiac healing post-myocardial infarction)
- **Skin wound healing** and chronic non-healing wounds
- **Nerve tissue regeneration**
- **Muscle fiber repair** and prevention of scar tissue formation
- **Chronic injuries** where inflammation and poor vascularization are limiting recovery

---

## What Is BPC-157?

**BPC-157** stands for **Body Protection Compound-157**, a 15-amino-acid peptide derived from a protective protein found in gastric juice. Unlike TB-500, which is a fragment of a naturally occurring regulatory protein, BPC-157 is a sequence not found naturally in the human body at significant concentrations outside the gut.

### Key Mechanisms of BPC-157

- **VEGF upregulation:** Promotes vascular endothelial growth factor expression, supporting new blood vessel formation
- **Growth hormone receptor sensitization:** Enhances tissue responsiveness to growth hormone
- **Nitric oxide modulation:** Improves blood flow to damaged tissue
- **Tendon and ligament fibroblast migration:** Directly promotes healing of connective tissue
- **Gut barrier protection:** Maintains intestinal epithelial integrity and counters gut damage from NSAIDs and other insults
- **Neuroprotection:** Evidence of dopaminergic and serotonergic modulation, with potential neurological applications

### What BPC-157 Is Best For

BPC-157 tends to show the strongest effects in:

- **Tendon and ligament injuries** — arguably the strongest evidence base for any peptide in this area
- **Gastrointestinal healing** (ulcers, leaky gut, IBD-like conditions in animal models)
- **Joint and cartilage repair**
- **Muscle tears and overuse injuries**
- **Post-surgical recovery** involving soft tissue

---

## TB-500 vs. BPC-157: Direct Comparison

### Mechanism

- **TB-500:** Works primarily through actin regulation and systemic cell migration; tends to have broader, system-wide effects
- **BPC-157:** Works primarily through VEGF, nitric oxide, and direct fibroblast stimulation; tends to have more targeted, local effects

### Injury Type

- **Tendon/ligament injuries:** BPC-157 has more direct, targeted evidence for tendon fibroblast repair; TB-500 supports healing through angiogenesis and reduced inflammation
- **Muscle injuries:** Both are effective; TB-500 may have an edge for large muscle belly tears and preventing scar tissue formation
- **Gut and GI issues:** BPC-157 is the clear choice — TB-500 has minimal evidence for gut-specific applications
- **Cardiac/systemic tissue:** TB-500 has the stronger evidence base for cardiac healing and systemic regeneration
- **Nerve injuries:** Both show some evidence; TB-500's mechanism through cell migration may be more relevant for peripheral nerve repair

### Administration

Both peptides are typically administered via **subcutaneous or intramuscular injection**. BPC-157 can also be taken **orally** for gut-targeted effects (with reduced systemic bioavailability). TB-500 is not considered effective via oral route.

### Dosing

- **TB-500:** Typical loading phase of 2–2.5 mg twice per week for 4–6 weeks, followed by a maintenance phase of 2 mg once per month
- **BPC-157:** 200–500 mcg per day, typically run for 4–8 weeks

### Safety Profile

Both peptides have favorable safety profiles in animal research, with no significant toxicity observed at or above human-equivalent doses. Neither has undergone formal human clinical trials.

---

## Should You Stack TB-500 and BPC-157?

Many practitioners and researchers argue that TB-500 and BPC-157 are **highly complementary** precisely because they work through different mechanisms. Combining them means:

- BPC-157 provides direct tendon fibroblast stimulation and VEGF-driven local angiogenesis
- TB-500 adds system-wide actin-mediated cell migration, anti-inflammatory support, and broader angiogenesis
- Together, they address healing from multiple angles simultaneously

The combination is particularly popular for:

- **Stubborn chronic injuries** that have not responded to either peptide alone
- **Post-surgical recovery** where comprehensive tissue healing is desired
- **Athletes** managing multiple concurrent overuse injuries

There are no known negative interactions between the two compounds in available research, and many users report significantly improved outcomes with the stack versus either peptide individually.

---

## Which Should You Choose?

Use this framework as a starting point:

**Choose BPC-157 if your primary concern is:**
- A tendon, ligament, or joint injury
- Gut or gastrointestinal healing
- A more targeted, localized injury

**Choose TB-500 if your primary concern is:**
- Systemic or widespread tissue healing
- Muscle repair and preventing scar tissue
- Cardiovascular or cardiac tissue (based on animal research)
- Neurological recovery

**Consider stacking both if:**
- You have a chronic, difficult injury
- You want to maximize healing speed and comprehensiveness
- You are recovering from significant surgery or trauma

---

## Finding Verified Sources

For either peptide, sourcing from a supplier with documented quality testing is essential. Look for HPLC purity certificates, mass spectrometry confirmation, and endotoxin testing from independent labs.

Browse the [Peptide Alliance directory](/peptides/performance-recovery) for verified suppliers carrying TB-500 and BPC-157 with documented quality testing and trust scores.

---

## Summary

TB-500 and BPC-157 are both exceptional healing peptides with strong preclinical evidence, but they are not duplicates. BPC-157 excels in targeted tendon, ligament, and gut healing through VEGF and fibroblast mechanisms. TB-500 provides broader systemic healing support through actin regulation, cell migration, and angiogenesis. For many use cases, combining the two is the most comprehensive and effective approach.`,
    is_published: true,
    published_at: NOW,
    generated_by: 'admin',
  },

];

// ── Insert posts ───────────────────────────────────────────────────────────────
async function main() {
  console.log(`Inserting ${posts.length} blog posts...\n`);

  for (const post of posts) {
    // Check for duplicate slug
    const { data: existing } = await supabase
      .from('blog_posts')
      .select('id')
      .eq('slug', post.slug)
      .maybeSingle();

    if (existing) {
      console.log(`  ⏭  Skipped (already exists): ${post.slug}`);
      continue;
    }

    const { error } = await supabase.from('blog_posts').insert(post);

    if (error) {
      console.error(`  ✗  Failed: ${post.slug}\n     ${error.message}`);
    } else {
      console.log(`  ✓  Inserted: ${post.slug}`);
    }
  }

  console.log('\nDone.');
}

main();
